Bispecific antibodies will mature after 2021, $6bn estimated sales in oncology by 2025: GlobalData Read more
SGLT-2 inhibitors may primarily drive growth of branded heart failure treatment market: GlobalData Read more
Top 20 global pharma companies by MCap saw 10.2 per cent rise in MCap in Q2 2020: GlobalData Read more
Informing payers and patients of biological therapy advantages can strengthen biosimilars market Read more
Neovascularization inhibitor sales will near $7 bn in diabetic retinopathy market in 2029: GlobalData Read more